Elsevier

Genomics

Volume 62, Issue 3, 15 December 1999, Pages 344-349
Genomics

Regular Article
Identification of a New Locus for Autosomal Recessive Charcot–Marie–Tooth Disease with Focally Folded Myelin on Chromosome 11p15

https://doi.org/10.1006/geno.1999.6028Get rights and content

Abstract

Autosomal recessive Charcot–Marie–Tooth disease type 4B (CMT4B) is a demyelinating hereditary motor and sensory neuropathy characterized by abnormal folding of myelin sheaths. A locus for CMT4B has previously been mapped to chromosome 11q23 in a southern Italian pedigree. We initially excluded linkage in two Tunisian families with CMT4B to chromosome 11q23, demonstrating genetic heterogeneity within the CMT4B phenotype. Subsequently, using homozygosity mapping and linkage analysis in the largest Tunisian pedigree, we mapped a new locus to chromosome 11p15. A maximum two-point lod score of 6.05 was obtained with the marker D11S1329. Recombination events refined the CMT4B locus region to a 5.6-cM interval between markers D11S1331 and D11S4194. The second Tunisian CMT4B family was excluded from linkage to the new locus, demonstrating the existence of at least a third locus for the CMT4B phenotype.

References (26)

  • C. Dib et al.

    A comprehensive genetic map of the human genome based on 5264 microsatellites

    Nature

    (1996)
  • A.A.W.M. Gabreëls-Festen et al.

    Congenital demyelinating motor and sensory neuropathy with focally folded myelin sheaths

    Brain

    (1990)
  • Cited by (70)

    • Identification of A Novel SBF2 Frameshift Mutation in Charcot-Marie-Tooth Disease Type 4B2 Using Whole-exome Sequencing

      2014, Genomics, Proteomics and Bioinformatics
      Citation Excerpt :

      However, most of these subtypes can only be differentiated through genetic tests. For instance, CMT4B1 is caused by mutations in the gene encoding MTMR2 on chromosome 11q22 [23–25], and mutations in the SBF2 gene have been identified in CMT4B2 on chromosome 11p15 [8,26]. At present, there are still no effective cures for CMT4; however, we can administer symptomatic treatments by the neurologist, physiatrist and orthopedic surgeon, such as special shoes for foot drop correction and walking assistance, surgery for severe pes cavus, exercise for recovery, and symptomatic treatments for pain, depression and other symptoms [4,27–29].

    • Charcot-Marie-Tooth disease

      2009, Presse Medicale
    • Mutations in FGD4 encoding the Rho GDP/GTP exchange factor FRABIN cause autosomal recessive Charcot-Marie-Tooth type 4H

      2007, American Journal of Human Genetics
      Citation Excerpt :

      We previously published the localization of CMT4H from one Lebanese family and one Algerian family with CMT4H.26

    • The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease

      2005, Journal of Biological Chemistry
      Citation Excerpt :

      Recently, genetic studies have identified MTMR2 and MTMR13 as genes mutated in a distinctive form of Charcot-Marie-Tooth peripheral neuropathy (7-11). CMT4B1 (MTMR2) and CMT4B2 (MTMR13) are autosomal recessive forms of demyelinating CMT, distinguished from other forms by the presence of a distinctive focal out-looping of myelin within peripheral nerves (4, 6, 7). These genetic findings, combined with the growing awareness that active MTMR phosphatases may be regulated via the association of inactive MTMR pseudophosphatases (26, 32, 52, 53), led us to investigate whether the MTMR2 and MTMR13 proteins might physically associate.

    • Autosomal Recessive Hereditary Motor and Sensory Neuropathies

      2005, Peripheral Neuropathy: 2-Volume Set with Expert Consult Basic
    View all citing articles on Scopus
    1

    To whom correspondence should be addressed at Division of Neurology, Department of Medicine, Duke University Medical Center, Box 2903, Durham, NC 27710-2903. Telephone: (919) 681-5696. Fax: (919) 681-7894. E-mail: [email protected].

    View full text